FDA Inspection 829353 — Cooperman Barnabas Medical Center Inc.

Cooperman Barnabas Medical Center Inc. — FEI 2273912

The FDA completed an inspection of Cooperman Barnabas Medical Center Inc. on Apr 29, 2013 in Livingston, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 29, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated
9421 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.